Related Experiment Video
Updated: Feb 6, 2026

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
Anti-NMDA Receptor Encephalitis Presenting as Acute Psychosis.
Tatiana Mengistu1, Anuj Subedi2, Uchenna Unamba2
1Ross University School of Medicine Miramar Florida USA.
Anti-NMDA receptor encephalitis can affect young adults with psychiatric symptoms and neurological decline. Early diagnosis and immunotherapy are crucial for recovery, even if tumors are absent.
Area of Science:
- Neurology
- Immunology
- Psychiatry
Background:
- Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an autoimmune disorder.
- It often presents with neuropsychiatric symptoms and neurological deficits.
Purpose of the Study:
- To highlight the importance of considering anti-NMDA receptor encephalitis in young adults with specific symptom clusters.
- To emphasize the need for early diagnosis and treatment.
Main Methods:
- Case review of young adults with acute psychiatric symptoms, neurological decline, catatonia, and autonomic instability.
- Diagnostic workup including neurological examination and potentially antibody testing.
- Treatment with immunotherapy.
Main Results:
- Patients presenting with this constellation of symptoms may have anti-NMDA receptor encephalitis.
- Absence of detectable tumors does not exclude the diagnosis.
- Prompt immunotherapy led to favorable neurological recovery in identified cases.
Conclusions:
- Anti-NMDA receptor encephalitis should be suspected in young adults with acute psychiatric symptoms and rapid neurological deterioration.
- Early immunotherapy is critical for achieving good neurological outcomes.
- The diagnosis is important even in the absence of associated tumors.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Internal Receptors
Receptor-mediated Endocytosis

